GBT Technologies Inc. Annual Performance Review

I’m putting together this guide to help you understand how GBT Technologies performed this year. Instead of digging through dense legal filings, we’ll break down the important facts so you can decide if this company fits your goals.

1. What does this company do?

GBT Technologies acts as a tech incubator. They use a "hub-and-spoke" model to develop, buy, and license technology in high-growth areas. Their portfolio includes wireless mesh networks, AI-driven healthcare monitoring, and IoT tracking. Their goal is to grow these technologies until they are ready to spin off into independent companies or joint ventures.

2. Major Wins and Recent Changes

The big news this year involves VisionWave Technologies (VWAV). GBT helped this company grow, and in July 2025, VisionWave went public on the NASDAQ. GBT and its subsidiary, GBT Tokenize, own a significant stake in VWAV, which serves as proof that their incubator strategy can produce results.

In early 2026, GBT started a joint venture with VisionWave and a partner called BOCA to work on defense tech. They assigned an "internal value" of $1 billion to this project. It is important to note that this figure is used for partnership leverage and does not represent actual market value or projected revenue.

3. Financial Health: Still in "Survival" Mode

The company’s finances are currently in a development phase:

• Ongoing Losses: GBT reported a loss of $721,551 for the year ending December 31, 2025. They rely on outside funding and selling stakes in their portfolio companies to cover operating costs.
• Lean Operations: As of December 31, 2025, the company operated with one full-time employee, relying on independent contractors for research and administrative work.
• Asset Management: The company’s balance sheet reflects the risks of early-stage investing, including a recent write-off of nearly $100,000 in loans to MetAlert.

4. Leadership Shake-up

In January 2026, the company appointed Patrick Bertagna as Interim CEO. His compensation package includes a $10,000 monthly salary, payable in cash or stock. Additionally, he is eligible to receive 1 billion shares if he successfully executes a reverse stock split and secures a listing on a major exchange. Investors should be aware that this structure creates the potential for significant share issuance, which can reduce the ownership percentage of existing shareholders.

5. Key Risks

Investing in GBT is highly speculative:

• Extreme Dilution: The company frequently issues new shares to fund operations, which can shrink your "slice of the pie" over time.
• OTC Market Risks: The stock trades on the "OTC Pink" market. This environment lacks the oversight of major exchanges, leading to higher volatility and a greater risk of market manipulation.
• Unproven Business Model: The BOCA deal includes a "sunset clause." If the project does not generate real revenue within 12 months, the deal can be canceled, which would impact the company's growth strategy.

6. The Bottom Line

GBT is a high-stakes venture. While they have successfully spun off a company onto the NASDAQ, their current finances are lean, and they are burning cash to maintain operations. The new leadership is focused on reaching a major exchange, but that path carries the risk of massive share dilution. View this as a venture capital-style play where the risk of total loss is high and profitability is not yet guaranteed. Before investing, consider whether your portfolio can handle the volatility associated with early-stage, OTC-traded companies.